Company Filing History:
Years Active: 2012
Title: Innovations by Jonathan Alexander Terret
Introduction
Jonathan Alexander Terret is a notable inventor based in Los Altos, California. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies.
Latest Patents
One of his key patents is titled "Human monoclonal antibodies to CD70." This patent provides isolated monoclonal antibodies that specifically bind to CD70 with high affinity. The disclosure includes nucleic acid molecules encoding these antibodies, expression vectors, and host cells for their expression. Additionally, it covers immunoconjugates, bispecific molecules, and pharmaceutical compositions that incorporate these antibodies. The methods outlined in the patent also focus on treating cancer, autoimmune diseases, inflammation, and viral infections.
Career Highlights
Jonathan Terret is associated with Medarex Inc., a company known for its innovative approaches in the field of immunotherapy. His work has contributed to advancements in therapeutic strategies that leverage the immune system to combat various diseases.
Collaborations
He has collaborated with notable colleagues such as Li-Sheng Lu and David J King, enhancing the research and development efforts within his field.
Conclusion
Jonathan Alexander Terret's contributions to the development of human monoclonal antibodies represent a significant advancement in biotechnology. His innovative work continues to impact the treatment of various medical conditions.